259 related articles for article (PubMed ID: 20696224)
1. Design and synthesis of 99mTc-citro-folate for use as a tumor-targeted radiopharmaceutical.
Altiparmak B; Lambrecht FY; Bayrak E; Durkan K
Int J Pharm; 2010 Nov; 400(1-2):8-14. PubMed ID: 20696224
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of receptor-based tumor imaging agent: (99m)Tc-folate-glucaric acid.
Onursal M; Lambrecht FY; Ozgur A
Int J Pharm; 2011 Sep; 416(1):288-92. PubMed ID: 21782912
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling of folate targeted multifunctional conjugate with Technetium-99m and biodistribution studies in rats.
Ak G; Yurt Lambrecht F; Sanlier SH
J Drug Target; 2012 Jul; 20(6):509-14. PubMed ID: 22643314
[TBL] [Abstract][Full Text] [Related]
4. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation.
Vaitilingam B; Chelvam V; Kularatne SA; Poh S; Ayala-Lopez W; Low PS
J Nucl Med; 2012 Jul; 53(7):1127-34. PubMed ID: 22693311
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy JA; Xu LC; Parker N; Vetzel M; Leamon CP
J Nucl Med; 2004 May; 45(5):857-66. PubMed ID: 15136637
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
8. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
9. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.
Müller C; Brühlmeier M; Schubiger PA; Schibli R
J Nucl Med; 2006 Dec; 47(12):2057-64. PubMed ID: 17138750
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and preliminary evaluation of a
Song M; Guo Z; Gao M; Shi C; Xu D; You L; Wu X; Su X; Zhuang R; Pan W; Liu T; Zhang X
Chem Biol Drug Des; 2017 May; 89(5):755-761. PubMed ID: 27910223
[TBL] [Abstract][Full Text] [Related]
11. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
Ayala-López W; Xia W; Varghese B; Low PS
J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging.
Lu X; Zhao L; Xue T; Zhang H
J BUON; 2013; 18(4):1074-81. PubMed ID: 24344042
[TBL] [Abstract][Full Text] [Related]
15. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
[TBL] [Abstract][Full Text] [Related]
17. Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection.
Giglio J; Fernández S; Jentschel C; Pietzsch HJ; Papadopoulos M; Pelecanou M; Pirmettis I; Paolino A; Rey A
Cancer Biother Radiopharm; 2013 Sep; 28(7):541-51. PubMed ID: 23651043
[TBL] [Abstract][Full Text] [Related]
18. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a novel 99mTc nitrido radiopharmaceutical with isopropyl xanthate, showing brain uptake.
Zhang J; Lin Y; Sheng X; Wang X
Appl Radiat Isot; 2009 Jan; 67(1):79-82. PubMed ID: 18760927
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
